Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer. [electronic resource]
Producer: 20200929Description: 3823 p. digitalISSN:- 2045-2322
- Antineoplastic Agents -- pharmacology
- Azepines -- pharmacology
- Cell Line, Tumor
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Prostatic Neoplasms, Castration-Resistant -- genetics
- Proto-Oncogene Proteins c-myc -- genetics
- Receptors, Androgen -- metabolism
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.